Keywords: lamictal, approved, pediatric, use, wellcome, new, anticonvulsant

LAMICTAL APPROVED FOR PEDIATRIC USE

Article | 23 May 1994

Print This

Wellcome's new anticonvulsant agent Lamictal (lamotrigine) has now had its license extended in the UK to include the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in